Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Albers

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Research|July 4, 2003
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cellsKazuaki Chikamatsu, Andreas Albers, Joanna Stanson, et al.
Head & Neck|December 17, 2008
Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progressionChristoph Bergmann, Laura Strauss, Eva Wieckowski, et al.
International Journal of Cancer|October 25, 2011
Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)Carsten Schaefer, Lisa H Butterfield, Sandra Lee, et al.
In Vivo (Athens, Greece)|February 24, 2021
Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysisMoonef Alotaibi, Valeria Valova, Toni HÄnsel, et al.
Oncotarget|October 28, 2020
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancerKonrad Klinghammer, Oliver Politz, Theresa Eder, et al.
Cancer Research|December 3, 2005
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neckAndreas Albers, Koji Abe, Jennifer Hunt, et al.
Medicina Clinica|December 18, 2008
[Detection of specific T cells for 264-272 and 149-157 peptides of p53 protein in peripheral blood of patients with breast cancer]Iñaki Alvarez-Busto, Andreas Albers, María Carmen Visus, et al.
Cancer Immunology, Immunotherapy : CII|June 30, 2009
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptideRonald C Hendrickson, Vito R Cicinnati, Andreas Albers, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Research|July 4, 2003
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cellsKazuaki Chikamatsu, Andreas Albers, Joanna Stanson, et al.
Head & Neck|December 17, 2008
Tumor-derived microvesicles in sera of patients with head and neck cancer and their role in tumor progressionChristoph Bergmann, Laura Strauss, Eva Wieckowski, et al.
International Journal of Cancer|October 25, 2011
Function but not phenotype of melanoma peptide-specific CD8(+) T cells correlate with survival in a multiepitope peptide vaccine trial (ECOG 1696)Carsten Schaefer, Lisa H Butterfield, Sandra Lee, et al.
In Vivo (Athens, Greece)|February 24, 2021
Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysisMoonef Alotaibi, Valeria Valova, Toni HÄnsel, et al.
Oncotarget|October 28, 2020
Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancerKonrad Klinghammer, Oliver Politz, Theresa Eder, et al.
Cancer Research|December 3, 2005
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neckAndreas Albers, Koji Abe, Jennifer Hunt, et al.
Medicina Clinica|December 18, 2008
[Detection of specific T cells for 264-272 and 149-157 peptides of p53 protein in peripheral blood of patients with breast cancer]Iñaki Alvarez-Busto, Andreas Albers, María Carmen Visus, et al.
Cancer Immunology, Immunotherapy : CII|June 30, 2009
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptideRonald C Hendrickson, Vito R Cicinnati, Andreas Albers, et al.
Pageof 2